Home » Topics » Regulatory » Patents

Patents
RSS

Substance P antagonists revealed by Boehringer Ingelheim

Feb. 18, 1998

Warner-Lambert reveals new protein farnesyltransferase inhibitors

Feb. 17, 1998

Dual inhibitors of PDE IV and TNF production prepared at Chiroscience

Feb. 17, 1998

SmithKline Beecham discovers nonpeptide G-CSF mimetics

Feb. 17, 1998

New GnRH antagonists from Merck & Co.

Feb. 17, 1998

Egis patents compounds affecting the central and peripheral serotonergic system

Feb. 16, 1998

Nonpeptide GnRH antagonists disclosed by Merck & Co.

Feb. 16, 1998

CCKB/gastrin receptor antagonists with anxiolytic activity discovered at Rotta

Feb. 16, 1998

Orally active iron chelators in development at Novartis

Feb. 16, 1998

Hypocholesterolemic agents disclosed by Warner-Lambert

Feb. 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...